$CURR News: Nicole Kidman, Sera Labs Strategic Business

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams Lee Adams #19466
74
$CURR News: Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021

Press Release | 04/13/2021
Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), announced today that Academy Award, Golden Globe and Emmy Award-winning actor/producer/entrepreneur Nicole Kidman and Sera Labs CEO/CURE Pharmaceutical Chief Strategic Officer, Nancy Duitch will headline Collision 2021. Collision is North America’s fastest-growing tech conference and brings together the world’s most sought-after founders, tech companies, and game-changing entrepreneurs of our time.

Sera Labs and CURE Pharmaceutical have the technology and are poised to set the new standard that will change how the world utilizes beauty, health and wellness products. Kidman and Duitch will discuss how cutting-edge delivery system technology, over a decade’s worth of research and development, seventeen published patents, and extensive expertise in proprietary encapsulation and polymer methodologies, which are fused into Sera Labs’ anti-aging beauty, health and wellness products, will demand attention and accomplish this beauty revolution.

“Speaking with Nicole at Collision is a milestone moment for the brand. Science and technology have always been cornerstones for our company success. The world watches what happens at Collision. We are excited to be there and share more about our cutting-edge anti-aging beauty technology,” said Duitch, Sera Labs CEO/Founder and CURE Pharmaceutical Chief Strategic Officer.

Collision will take place virtually on its proprietary software from April 20-22, 2021, and is expected to attract over 40,000 attendees from over 100 countries. To learn more about the Collision Conference, visit https://collisionconf.com/. Kidman and Duitch will be headlining day two of the conference.

For more information on Seratopical by Sera Labs, please visit, Seratopical.com and follow us @seratopical.

About Sera Labs
Sera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD and clean plant-based products. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical™, SeraLabs™, and Gordon’s Herbals™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness. Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: Seratopical.com, seralabshealth.com and follow us on Instagram at @seratopical, as well as Twitter, and Facebook. Media contact: press@theseralabs.com.

About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.


View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005490/en/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advenica: Rising Star in Secure File Transfer Market

Updated Category News Views 1

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Continue Reading
KuCoin's KCUSD Tackles Stablecoin Idle Capital Problem

Updated Category News Views 1

KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...

Continue Reading
Europe's Largest Carbon Capture Facility Launches

Updated Category News Views 2

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

Continue Reading
Sungrow's MGTL Series: A Game-Changer in Solar Tech

Updated Category News Views 2

Smarter Energy Systems Are Here Gone are the days when solar inverters were just clunky bits of tech you threw on a roof. Sungrow's latest MGTL Series, revealed in Da Nang, marks a revolutionary step for Southeast Asia, Africa, Latin America, and beyond. They're not just talking the talk—they're bringing real innovation to the table. Why the MGTL Series Stands Out Look,...

Continue Reading
Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Updated Category News Views 2

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Continue Reading
Michigan Roof Inspections: Seasonal Insights That Count

Updated Category News Views 3

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 3

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Overpricing in Atlanta Luxury Real Estate: Risks & Rewards

Updated Category News Views 4

When Pricing Sends the Wrong Message Jump into the high stakes poker game of Atlanta's luxury real estate, and you'll find that pricing strategy is your make-or-break move. Jud Whitlock, a seasoned veteran over at Atlanta Fine Homes/Sotheby's International Realty, lays it all down: in this digital age, pricing too high is akin to waving a red flag at savvy buyers armed...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 1

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
DNOW Faces Class Action: Proxy Missteps Under Fire

Updated Category News Views 1

DNOW's Rough Patch: Investors, Beware Here's a tangled mess for you: DNOW Inc., a name that should've been cruising post-merger, now finds itself smack in the middle of a class action lawsuit. Blame it on some botched acquisition moves with MRC Global Inc. The suits claim DNOW's management may have played fast and loose with the truth during their big merger spiel. When...

Continue Reading

Top 5 Most Recently Viewed Articles

Semler Scientific, Inc. Faces Investor Legal Action Opportunities

Updated Category News Views 128

Investing in Semler Scientific, Inc. (NASDAQ: SMLR) Investors in Semler Scientific, Inc. have found themselves at a crucial crossroads as the company faces significant allegations regarding securities fraud. This situation presents an opportunity for investors to consider what steps they can take to safeguard their investments and potentially recover losses incurred....

Continue Reading
Flywire Corporation Set to Showcase at Major Tech Conference

Updated Category News Views 129

Flywire Corporation to Attend Major Investor Conference Flywire Corporation (NASDAQ: FLYW) has recently announced its participation in the highly anticipated UBS Global Tech and AI Conference. The event will take place in Phoenix, Arizona. The Company's session is scheduled for 7:35 am MST, where they will engage in an insightful fireside chat. Webcast and Replay Details...

Continue Reading
Nuance Pharma Boosts Bentrio Availability Across Asia Regions

Updated Category News Views 145

Nuance Pharma Expands Distribution for Bentrio Nasal Spray Nuance Pharma is making significant strides by enhancing its exclusive license and distribution agreement with Altamira Medica Ltd. This updated contract now extends coverage to seven additional countries in East and Southeast Asia. The announcement was made by Altamira Therapeutics Ltd. (NASDAQ: CYTO), the parent...

Continue Reading
Investigation on Crocs Holdings: Your Rights as an Investor

Updated Category News Views 128

Investor Alert: Ongoing Investigation into Crocs Holdings Faruqi & Faruqi, LLP is actively investigating the financial practices of Crocs, Inc. (NASDAQ: CROX) amidst mounting concerns over the company's revenue reporting and overall operations. For investors holding substantial stakes in Crocs, understanding the implications of this investigation is crucial for protecting...

Continue Reading
NovaBridge's New Leaders Accelerate VIS-101 Development

Updated Category News Views 221

Strategic Appointments Propel VIS-101 Forward In an exciting development for VIS-101, NovaBridge Biosciences has appointed two distinguished leaders in ophthalmology, Cadmus C. Rich, MD, MBA, as Chief Medical Officer and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board. Their expertise will significantly enhance the clinical development of this...

Continue Reading